Investigational Site Number: 8260005

London SW17 0RE

1 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Non-relapsing Secondary Progressive Multiple Sclerosis

Studies at this site

• A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease — Recruiting now
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed